Press Release 2019 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sabinsa Awarded New Patents for ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims

Sabinsa’s Biotechnology Site Achieves USP GMP Audited Status

Sabinsa Launches LactoSporin®: Novel Probiotic Metabolite For Skin and Hair

Sabinsa Scientist Dr. Natarajan honored by IASTAM for Nutraceutical Product Development

Sabinsa Shagandha™ Ashwagandha Root Extract 2.5% Designed to Meet USP Monograph, Verified by Prominent Botanical Testing Expert Alkemist Labs

Published Study Reaffirms Function and Survival of Sabinsa’s LactoSpore®

Certificates

Global Offices

Get in Touch

Disclaimer